SUPPORT-D Group for Alzheimer's Disease

Phase-Based Progress Estimates
Medical University of South Carolina, Charleston, SCAlzheimer's Disease+1 MoreA Program of SUPPORT-D (dementia) - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial tests a nurse-led intervention to help improve quality of life for people living with Alzheimer's and their caregivers, and to make them safer in the community.

Eligible Conditions
  • Alzheimer's Disease
  • Mild Cognitive Impairment

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

18 Primary · 0 Secondary · Reporting Duration: at study completion, an average of 8 weeks

Week 8
Acceptability of Intervention Measure (AIM) score
Appropriateness of Intervention score
Change in feasibility score
Number of participants completing advance care planning documents
Week 8
Change in Perceived Stress scale score
Alzheimer's Disease
Change in Safety assessment scale score
Change in Symptom burden anxiety score
Change in Symptom burden depression score
Change in Symptom burden fatigue score
Change in Symptom burden pain score
Change in Symptom burden physical function score
Change in Symptom burden satisfaction with social role score
Change in Symptom burden sleep quality score
Change in self-efficacy for caregiving score
Change in technology literacy score
Week 8
Change Zarit caregiver burden score
Change in Alzheimer's Disease Knowledge Scale (ADKS) score

Trial Safety

Trial Design

1 Treatment Group

1 of 1

Experimental Treatment

60 Total Participants · 1 Treatment Group

Primary Treatment: SUPPORT-D Group · No Placebo Group · N/A

Experimental Group · 1 Intervention: A Program of SUPPORT-D (dementia) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at study completion, an average of 8 weeks

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
39,835 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
199 Previous Clinical Trials
355,894 Total Patients Enrolled
Medical University of South CarolinaLead Sponsor
851 Previous Clinical Trials
5,389,916 Total Patients Enrolled
Diana M Layne, PhDPrincipal InvestigatorMedical University of South Carolina

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You do not have any issues with memory or thinking.
You take care of someone who has Alzheimer's disease or you think they might have it.
You have Alzheimer's disease, and the study expects you to have trouble with your memory and thinking. You are 18 years old or older.
You have been diagnosed with Alzheimer's disease or have symptoms of Alzheimer's disease within the last 12 months.

Frequently Asked Questions

Is there an ongoing opportunity to join this trial?

"As indicated on the platform, this medical trial is still recruiting patients and commenced in December of 2022; further updates were made to the study that same month." - Anonymous Online Contributor

Unverified Answer

What is the current tally of participants in this research endeavor?

"Affirmative, the details posted on indicate that this trial has begun recruiting participants. The initial posting was made December 1st 2022 and recently updated on the same day. 60 patients are required to be recruited from a single medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.